Literature DB >> 8043859

Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes.

J Tamaru1, M Hummel, M Zemlin, B Kalvelage, H Stein.   

Abstract

The nature of Hodgkin and Reed-Sternberg (HRS) cells remains in question. Immunophenotypic studies favor a relation to the lymphoid lineage with the existence of B- and T-cell types. However, studies on the detection of antigen (Ag) receptor gene rearrangements provided inconsistent results. They concur in that rearranged Ig and T-cell receptor (TCR) genes are not demonstrable in most Hodgkin's disease (HD) cases. To clarify whether this is because of the insensitivity of the method of detection or a real absence of clonal Ig heavy chain (IgH) rearrangements, a polymerase chain reaction (PCR) method with high sensitivity was applied, allowing the detection of less than 50 cells with clonally rearranged IgH genes in a mixture of 100,000 germline or individually rearranged cells. In 67 cases of HD, most of those (67%) with B-Ag+ HRS cells express clonal VDJ rearrangements of the IgH gene. No cases with T-cell Ag+ HRS cells harbored detectable clonal VDJ rearrangements. Of 10 sequenced rearranged IgH genes, the VH segment of six contained considerable somatic mutations. These results suggest that the demonstrated VDJ rearrangements stem from the HRS cells themselves and that the HRS cells of cases with rearranged IgH genes are B-cell related and correspond in their differentiation stage either to naive pregerminal center B cells or (more commonly) to germinal center/postgerminal center-derived memory B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043859

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Unraveling the mystery of the lymphoid follicle.

Authors:  O W Kamel
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Rapid proliferation of a different clone early after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  Takehiko Mori; Junichi Tamaru; Michihide Tokuhira; Shigehisa Mori; Hiroshi Suzuki; Toru Abe; Tsutomu Takeuchi
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

4.  Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas.

Authors:  M Nihal; D Mikkola; G S Wood
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

5.  Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?

Authors:  G S Pinkus; J L Pinkus; E Langhoff; F Matsumura; S Yamashiro; G Mosialos; J W Said
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.

Authors:  J Tamaru; M Hummel; T Marafioti; B Kalvelage; L Leoncini; C Minacci; P Tosi; D Wright; H Stein
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

7.  IgH PCR of zinc formalin-fixed, paraffin-embedded non-lymphomatous gastric samples produces artifactual "clonal" bands not observed in paired tissues unexposed to zinc formalin.

Authors:  Kim Ahrens; Raul Braylan; Nidal Almasri; Robin Foss; Lisa Rimsza
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

8.  [U-HO1. A new cell line derived from a primary refractory classical Hodgkin lymphoma].

Authors:  P Möller; A Mader; T F E Barth; S Brüderlein
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

9.  PCR clonality detection in Hodgkin lymphoma.

Authors:  K M Hebeda; M C Van Altena; P Rombout; J H J M Van Krieken; P J T A Groenen
Journal:  J Hematop       Date:  2009-02-20       Impact factor: 0.196

10.  Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  J J Oudejans; J A Kummer; M Jiwa; P van der Valk; G J Ossenkoppele; P M Kluin; J C Kluin-Nelemans; C J Meijer
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.